Eli Lilly is in advanced discussions to acquire Kelonia Therapeutics in a deal valued at more than $2 billion, signaling a strong push into next-generation cancer treatments.
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have entered into a strategic partnership to support the development and manufacturing of antibody-drug conjugates (ADCs), an emerging class of targeted cancer therap...
Indian pharma companies are witnessing a sharp drop in semaglutide API price even as demand for GLP-1 drugs surges across the country. The fall comes right after the patent expiry of semaglutide in India, which has opened the market to a wave of...
India’s radiotherapy device market is entering a high-growth phase, driven by a sharp rise in cancer cases, expanding healthcare infrastructure, and increased public investment in oncology care. Industry estimates indicate the market could more...
The Indian government has outlined a clear strategy to transform the country’s pharmaceutical sector from being the “Pharmacy of the World” — known for affordable generics — to a global leader in high-value innovations, especially biologic...
The C4 Therapeutics & Roche cancer deal has taken a major step forward as both companies expand their partnership in a move that could exceed USD 1 billion. The updated agreement strengthens their focus on developing new cancer treatments using...
India’s pharmaceutical industry is likely to see pressure on its earnings from the US market in the coming quarter, even though domestic growth remains strong, according to a report by Nuvama Institutional Equities.
Alkem Laboratories Ltd. today announced the launch of A to Z Daily, an everyday multivitamin supplement for adults, for providing holistic nutritional support to the body and mind.
Kiran Mazumdar-Shaw has raised concerns over India’s listing rules, saying the current system fails biotech startups in India. She urged to rethink IPO norms for Biotech startups.
Senores Pharmaceuticals has taken a major step forward in its global growth journey by announcing a strategic joint venture to expand its presence in the United States federal healthcare market. This move highlights the company’s ambition to stren...
.jpg)
, CDSCO.jpg)